Novavax, Inc, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced that Nuvaxovid (NVX-CoV2373) has been recommended for full Marketing Authorization...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been...
Advent Technologies Holdings, Inc., an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce that its Green HiPo project...
